1 Ocak 2021 Dergi makalesi Açık Erişim

Inandiklioglu, Nihal; Koklu, Betul; Sahin, Seliha; Guleryuz, Naciyenur; Akyuz, Enes

Dublin Core

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Inandiklioglu, Nihal</dc:creator>
  <dc:creator>Koklu, Betul</dc:creator>
  <dc:creator>Sahin, Seliha</dc:creator>
  <dc:creator>Guleryuz, Naciyenur</dc:creator>
  <dc:creator>Akyuz, Enes</dc:creator>
  <dc:date>2021-01-01</dc:date>
  <dc:description>Objectives: Cytokines are thought to be involved in the pathogenesis of many neurological diseases such as epilepsy. It is predicted that interleukin (IL)-1 beta and IL-6 levels in brain tissue are effective in the initiation and maintenance of epileptic seizures. However, there is no study addressing the inflammatory process in the lung in epileptic conditions. It was aimed to contribute to the mechanism of respiratory pathologies accompanying epilepsy in this study.</dc:description>
  <dc:identifier>https://aperta.ulakbim.gov.trrecord/235996</dc:identifier>
  <dc:identifier>oai:aperta.ulakbim.gov.tr:235996</dc:identifier>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://www.opendefinition.org/licenses/cc-by</dc:rights>
  <dc:source>EPILEPSI 27(4) 205-211</dc:source>
  <dc:title>Expression of Lung IL-1 beta and IL-6 in Pentylenetetrazol-Kindling Model Epilepsy</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>